期刊文献+

慢性乙肝病毒携带者外周血T细胞亚群的变化及其与血清HBVDNA的关系研究 被引量:2

Association of the chang of T cell subset with HBV DNA levels in chronic hepatitis B-virus carriers
下载PDF
导出
摘要 目的研究慢性乙肝病毒携带者(AsC)的细胞免疫功能变化及临床意义,探讨其与血清HBVDNA的关系。方法对120例慢性乙肝病毒携带者和60例健康人应用流式细胞仪直接免疫荧光法检测外周血T淋巴细胞亚群的百分率,并进行比较。结果乙肝病毒携带者外周血CD3^+、CD4^+细胞数百分率及CD4/CD8与健康对照组比较明显降低(P〈0.01);CD8^+细胞数百分率较健康对照组明显升高(P〈0.01);血清HBVDNA(+)组与HBVDNA(-)组相比,CD3^+细胞数百分率无统计学差异(P〉0.05),CD4^+细胞数百分率及CD4^+/CD8^+比值明显降低(P〈0.01),CD8^+细胞数百分率明显升高(P〈0.01)。将HBVDNA(+)组按高、中、低病毒载量分组进行比较,各项指标均无统计学意义(P〉0.05)。但CD4^+、CD4^+/CD8^+在数值上呈下降趋势,CD8^+呈上升趋势。结论HBV感染后可导致乙肝病毒携带者细胞免疫功能降低,HBVDNA复制进一步加重紊乱。 Objective To study the significance of the change of T cell subsets and find out the influence of HBV DNA levels on function of cellular immunity in hepatitis B-virus carders. Methods Peripheral T cell subsets in 120 chronic HBV carriers and 40 health control groups were determined by direct immunofluorescence using flow cytometry. Result The rate of CD3^+ cell, CD4^+ cell and CD4/CD8 were significantly reduced (P〈0.01 ), and CD8^+ cell was significantly increased (P〈0.01 ) in 120 symptomatic HBV carriers as compared with health control groups. The rate of CD3^+ cell in HBV DNA (+) carriers showed no significant difference from those of HBV DN (-) carders. The rate of CD8^+ cell was significantly increased (P〈0.0 1) as compared with HBV DNA (-) carriers. There was no significantly difference as compared with difference HBV DNA levels, but the rate of CD4^+ cell and CD4/CD8 were lower, CD8^+ cell was higher with increasing levels of HBV DNA in HBV DNA (+) carriers. Conclusions These findings suggest that the disorder of cellular immunity in patients with hepatitis B would be caused by HBV infected, and the increasing of HBV DNA in subset can make the disorder advanced.
出处 《世界感染杂志》 2006年第3期196-198,207,共4页 World Journal of Infection
关键词 慢性乙肝病毒携带者 HBVDNA T淋巴细胞 免疫耐受 Chronic B-virus carriers HBV DNA T-cell subset Immune tolerance
  • 相关文献

参考文献13

  • 1Sigal LJ, Crotty S,Andino R, et al, Cytotoxic T-cell immunity to virusinfected non-haematopoietic cells requires presentation of exogenous antigen[J]. Nature, 1999, 398: 77-80.
  • 2Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection [J].Hum Mol Genet, 2003, 12(19): 2541-2546.
  • 3骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社,2001.337-338.
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14014
  • 5Sieg S, Huang Y, Kaplan D. Viral regulation of CD95 expression and apoptosis in T lymphocytes[J]. J Immunol, 1997, 259(3): 1193-1199.
  • 6Nakamura K, Yuh K, Sugyo S, et al. Apoptosis observable in peripheral T lymphocytes from patients with chronic hepatitis B[J].Gastroenterology, 1996, 111 ( 1): 156-164.
  • 7李玲,顾长海,李欣,颜杰,刘俊.慢性乙型肝炎患者PBMCFas表达和凋亡的检测及意义[J].第三军医大学学报,2001,23(6):713-715. 被引量:17
  • 8乔燕伟,游晶,庄林,陈红英,俞岚,高惠芸,吴国宾,曲俊彦.慢性HBV携带者外周血T细胞亚群的不同年龄变化[J].世界华人消化杂志,2005,13(1):35-38. 被引量:14
  • 9李乐,蔡鹏威,伍严安,陈旭征.慢性乙肝病毒携带者的细胞免疫功能变化及其与血清HBV DNA的关系[J].福建医药杂志,2003,25(6):18-20. 被引量:21
  • 10Chisari F V, Ferrari C. Hepatitis B virus immunopothogenesis[J].Annu Rev Immunol, 1995, 13: 29-60.

二级参考文献30

  • 1范淳,刘林.慢性乙肝患者杀伤性免疫细胞功能的研究[J].免疫学杂志,1996,12(1):43-47. 被引量:14
  • 2[3]Chu CM, Liaw YF. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers. Cell Immunol, 1986, 98 (2): 533 ~ 537.
  • 3[4]Baroja ML, Sirit FL, Caldera DJ. Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signals. Clin Immunol Immunopathol. 1993, 69 (2):180~188.
  • 4[5]Yoffe B, Noonan CA, Melnick JL, et al. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis, 1986,(3):471~477.
  • 5[7]Guidotti LG, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during acute HBV infection. Science,1999, 284 (5415): 825~829.
  • 6[8]Shen HD, Choo KB, Lee SD, et al. Hepatitis B virus DNA in leukocytes of patients with hepatitis B virus-associated liver diseases. J MedVirol, 1986, 18 (3): 201~211.
  • 7Juszczyk J. Clinical course and consequences of hepatitis B infection. Vaccine 2000;18:S23-25.
  • 8陈慰峰.医学免疫学(第3版)[M].北京:人民卫生出版社,2001.82-83.
  • 9骆抗先.乙型肝炎基础和临床(第2版)[M].北京:人民卫生出版社,2001.415-435.
  • 10Sieg S,J Immunol,1997年,159卷,3期,1193页

共引文献14116

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部